
Sign up to save your podcasts
Or


A viral capsid evolved inside human T cells generated CAR-T cells in a living mouse from a single systemic dose, and a screen names the surface protein that lets it in. An open research agent published the control that embarrasses it: with the labels shuffled, some of its hypotheses stayed statistically supported. A benchmark that hands agents a deliberately broken simulator found most models' nominal 95% intervals covering the truth between a fifth and two thirds of the time, and asking the model to be humble did not help. The WHO estimates three in five women aged 30 to 49 have never been screened for cervical cancer, with HPV testing reaching one woman in fifty in poorer countries. And the FDA will start handing its own review packages to regulators abroad.
Sources: https://lucafusarbassini.org/d/2026-11-18
A single-cell method that sequences the genome edit itself, rather than the guide RNA that was supposed to make it, finds off-target edits in cells whose guides had all passed specificity filtering. A small open benchmark takes the confidence score most protein designers use to rank candidate binders and shows it performing at chance against which designs actually bound. An oral drug for early Alzheimer's missed in the whole trial population and met its threshold in a subgroup allocated its own share of the alpha. An evaluation lab reports that agents can now tell an alignment test from an ordinary task. And Tunisia says switching to electronic submission cut the wait for a medicine's marketing authorisation from more than three years to eight months.
Sources: https://lucafusarbassini.org/d/2026-11-17
The US Food and Drug Administration refused ivonescimab in lung cancer: progression slowed sharply, survival did not separate, and the agency said that was not enough. A preprint reports small molecules that glue a cancer peptide onto class I MHC, so an antigen the cell never displayed becomes displayable. The World Health Organization published its first guidelines on type 1 diabetes in adults, written to hold in refugee camps as well as in teaching hospitals. A German-language report on a study in four Chinese hospitals finds junior doctors spotted about one in six hallucinations deliberately planted in AI output. And a mathematician walks through why "checked in Lean" is not yet a check when the Lean was written by a machine.
Sources: https://lucafusarbassini.org/d/2026-11-16
A Nature paper shows that purine nucleotides work as molecular glues, holding the enzyme that makes purines against its inhibitor, and that thiopurine drugs in use since the 1950s glue the same pair. In rural Lesotho, a cluster-randomised trial let trained community health workers prescribe blood-pressure drugs themselves, and control held as well as in nurse-led clinics. Agents at Google DeepMind wrote over six million lines of Lean to prove security properties of Signal's compiled code in four weeks, while a separate Google team's agents formalised the Weil conjectures. When ten language models agree about a health claim, a Scientific Reports paper finds, they are often jointly wrong. And the WHO's tuberculosis report counts 2.2 million people who fell ill and were never diagnosed or never reported.
Sources: https://lucafusarbassini.org/d/2026-11-15
The US Food and Drug Administration approved the first factor XIa inhibitor, asundexian, to prevent a second stroke, on a trial in which major bleeding barely moved. On the same day it required GLP-1 drugs to carry a warning for a sudden, untreatable optic-nerve infarction. Around that class, three trials pushed in new directions: resistance training that keeps muscle on tirzepatide, retatrutide easing knee osteoarthritis pain, and an oral GLP-1 pill reducing sleep apnoea. A Cell paper orders samples along development and disease without being told the order, and a Nature Medicine taxonomy sorts ulcerative colitis patients by the shape of their response. And a team of a thousand AI agents formalised Fermat's Last Theorem in Lean in about thirty hours.
Sources: https://lucafusarbassini.org/d/2026-11-10
The peer-reviewed papers behind last week's heart meeting arrived, and the companion analysis of the big lipoprotein(a) trial closes the last escape route: the patients whose marker fell most did no better. A programme that trained dispatchers, first responders and residents across sixty North Carolina counties left cardiac-arrest survival where it was. Two Chinese trials of a clot-dissolving drug injected into the artery after mechanical clot removal were null on ninety-day function. Against that, a single combination pill delivered by a retrained primary care team more than doubled blood-pressure control in Colombia and Jamaica, and a weight-loss drug moved an invasively measured pressure in heart failure. And a preprint reports that the enzyme that makes fat is also an RNA-binding protein.
Sources: https://lucafusarbassini.org/d/2026-11-09
At the American Heart Association meeting, an antisense drug cut a genetic cardiovascular risk marker by more than three quarters, and the heart attacks and strokes it is supposed to predict did not become fewer; an anti-inflammatory antibody did the same for two markers of inflammation, with the same result.
Sources: https://lucafusarbassini.org/d/2026-11-08
A preprint argues that the unit of a bespoke antisense therapy is not the patient but the haplotype pair, so a panel of four oligonucleotides can be prepared in advance for a population.
Sources: https://lucafusarbassini.org/d/2026-11-06
CVS Health will split in two, separating its insurer and pharmacy-benefit business from its pharmacies and walk-in clinics.
Sources: https://lucafusarbassini.org/d/2026-11-05
Nusinersen, the splice-switching oligonucleotide given to infants with spinal muscular atrophy since 2016, also activates its target gene's promoter thirty kilobases away, by a mechanism the splicing assay the field runs cannot see.
Sources: https://lucafusarbassini.org/d/2026-11-04
From the publisher's feed
The ex-Biotech Futurist channel will now experimentally host the Paper Boat Radio, delivering daily news in Biology. The 2023 series of The Biotech Futurist stays available.